Home Category Region Publishers About Us Contact Us
Home > Market Research Report > Medical Device > Orthopedic > Microelectronic Medical Implants: Products, Technologies and Opportunities
Category
Medical Device (4398)
Cardiovascular Device (252)
Catheter Equipment (209)
CT and MRI and X ray (146)
Dental Equipment (177)
Disposable Medical Device (83)
Endoscopy Equipment (114)
Healthcare IT (310)
In Vitro Diagnostics Equipment (435)
Medical Imaging (425)
Molecular Imaging/Agents (29)
Nuclear Medical (76)
Ophthalmic Equipment (105)
Orthopedic (343)
Patient Monitoring (384)
Ultra Sound (50)
Wound Care (120)
Market Research Report

Microelectronic Medical Implants: Products, Technologies and Opportunities

Published by BCC Research
Published June, 2007 Product code 52895
Content info 157 pages 39 tables
Price
Not Available

This publication has been discontinued on June 7, 2011.

Below is the updated product.

Microelectronic Medical Implants: Products, Technologies & Opportunities
Published: May, 2011
Product code: 196809

Introduction

Abstract

INTRODUCTION

The first microelectronic medical implant (MMI) was introduced over 45 years ago and remains to be the best-known pacemaker. Assisting people with weak or failing hearts in living longer, fuller lives has continued to be a major focus of medical implant R&D. The pacemaker has been followed by a variety of other implantable cardiac devices, including defibrillators, loop recorders, heart assists, and even heart replacements.

Neurostimulators, implantable devices that employ the same principles as pacemakers for the purposes of neural stimulation, have also been introduced. Neurostimulators were used initially for pain relief, but are now being used for other neurological indications ranging from the treatment of urge incontinence to preventing epileptic seizures.

Other therapeutic implantable devices have followed, including bone growth stimulators, drug infusion pumps, and ear implants that provide a semblance of hearing for the deaf. Eye implants that can restore limited vision to people with certain types of blindness are under development and may become a commercial reality around the end of this decade.

SCOPE OF STUDY

This report contains:

  • Major implant types and applications, both commercial and developmental
  • Global market size and segmentation, including historical data on sales by application and implant type
  • Market drivers and constraints.
  • Detailed market projections through 2012
  • Industry structure, competition, and market shares
  • Factors that may influence the long-term market for microelectronic implants.

METHODOLOGY AND INFORMATION SOURCES

The findings and conclusions of this report are based on information gathered from manufacturers and distributors of microelectronic implants, hospitals, doctors, and other end users. Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature, and online databases to produce the baseline market estimates contained in this report.

The base year for analysis and projection is 2006. In cases where year-end data for 2006 was unavailable, figures were extrapolated from 2005 demand statistics and historical trends.

With 2006 as a baseline, market projections were developed for 2007 to 2012. These projections are based on a combination of a consensus among the primary contacts combined with our understanding of the key market drivers and their impact from a historical and analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in the section on Detailed Market Projections.

All dollar projections presented in this report are in 2006 constant dollars.

Table of Contents

  • INTRODUCTION
    • MICROELECTRONIC MEDICAL IMPLANTS
    • STUDY BACKGROUND
    • STUDY GOALS AND OBJECTIVES
    • INTENDED AUDIENCE
    • SCOPE OF THE STUDY
    • METHODOLOGY AND INFORMATION SOURCES
    • ANALYST CREDENTIALS
    • OTHER RELEVANT BCC REPORTS
    • BCC ONLINE SERVICES
    • DISCLAIMER
  • EXECUTIVE SUMMARY
    • Summary Table:
    • GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS BY APPLICATION, THROUGH 2012 ($ BILLIONS)
    • Summary Figure:
    • GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS BY APPLICATION, 2006-2012 ($ BILLIONS)
      • EXECUTIVE SUMMARY (CONTINUED)
  • OVERVIEW OF MICROELECTRONIC IMPLANTS
    • GENERAL DESCRIPTION
      • DEFINITION
      • HISTORY OF MICROELECTRONIC IMPLANTS
        • Early Origins
        • Early Pacemakers
        • Advances in Pacemaker Technology
        • First Implantable Defibrillator
        • Neurostimulators
        • First Implantable Drug Pump
        • Cardiac Assist/Replacement Devices
        • Ear Implants
        • Eye Implants
  • TECHNOLOGIES
    • MINIATURIZATION
    • MATERIALS
    • SENSORS
    • POWER SUPPLIES
    • RF TECHNOLOGY
  • APPLICATIONS
    • CARDIOVASCULAR DISEASE
    • Table 1 HOSPITALIZATIONS, PHYSICIAN OFFICE VISITS, AND DEATHS DUE TO HEART DISEASE IN THE U.S., 2001-2002*
      • Brachycardia
      • Hypertrophic Cardiomyopathy
      • Tachyarrhythmia
      • Syncope
      • Heart Failure
    • NEUROLOGICAL DISEASES/CONDITIONS
      • Chronic Pain
      • Spinal Cord Injuries
      • Parkinson' s Disease
      • Epilepsy
      • Depression
      • Muscle Spasticity
      • Urge Incontinence
      • Other Conditions
      • Alzheimer' s Disease
    • BONE DAMAGE
    • DIABETES
    • CANCER
    • Figure 1 TRENDS IN U.S. CANCER DEATHS, 1998-2006
      • IMPAIRED HEARING
      • BLINDNESS
    • PRODUCT TYPES
      • CARDIAC IMPLANT
        • Pacemakers
        • Description
        • Applications
        • Technology
        • Manufacturers
    • Table 2 HEART PACEMAKER MANUFACTURERS
      • Patent Analysis
    • Figure 2 PACEMAKER PATENT HOLDERS (% OF TOTAL PACEMAKER PATENTS)
      • Implantable Cardioverter Defibrillators
        • Description
        • Applications
        • Technology
        • Manufacturers
    • Table 3 IMPLANTABLE DEFIBRILLATOR MANUFACTURERS
      • Patent Analysis
    • Figure 3 ICD PATENT HOLDERS (%)
      • Cardiac Resynchronization Therapy Device
        • Description
        • Applications
        • Technology
        • Manufacturers
    • Table 4 CARDIAC RESYNCHRONIZATION DEVICE MANUFACTURERS
      • Patent Analysis
    • Figure 4 CARDIAC RESYNCHRONIZATION DEVICE PATENT HOLDERS (% OF TOTAL PATENTS ISSUED THROUGH MARCH 1. 2007)
      • Implantable Loop Recorders
        • Description
        • Applications
        • Technology
        • Manufacturers
        • Patent Analysis
    • Cardiac Replacement/ Assist Devices
      • Description
      • Applications
      • Technology
        • Technology (Continued)
    • Table 5 HEART ASSIST DEVICES
      • Ventricle Assisted
      • Pulsatile vs. Continuous Flow Pumping
      • Percutaneous vs. Transcutaneous Devices
      • Power Source
      • Other Technical Developments
      • High-Performance Materials
      • Greater Longevity
      • Miniaturization
      • Manufacturers
    • Table 6 CARDIAC REPLACEMENT/ASSIST DEVICE MANUFACTURERS
      • Patent Analysis
    • Figure 5 CARDIAC ASSISTANCE/REPLACEMENT DEVICE PATENT HOLDERS (PERCENT OF TOTAL U.S. PATENTS)
    • Figure 5 (CONTINUED)
      • NEUROSTIMULATORS
        • Spinal Nerve Stimulators
          • Description
          • Applications
          • Technologies
            • Spinal Nerve Stimulators for Chronic Pain
            • Spinal Stimulators for Spinal Cord Injury
            • Freehand
            • Vocare
            • Dobelle Implantable Breathing Pacemaker
            • Recent Developments in Spinal Nerve Stimulators for SCI
            • Spinal Nerve Stimulators for Urge Incontinence
          • Manufacturers
    • Table 7 SPINAL CORD STIMULATOR MANUFACTURERS
      • Recent Patents
    • Vagal Nerve Stimulator
      • Description
      • Applications
      • Technology
      • Manufacturers
      • Patent Analysis
    • Gastric Nerve Stimulation
      • Description
      • Applications
      • Technology
      • Manufacturers
      • Patents
    • Figure 6 GASTRIC ELECTRICAL STIMULATION TECHNOLOGY PATENTS (% OF TOTAL CORTICAL STIMULATION PATENTS)
      • Cortical Stimulation
      • Description
      • Applications
        • Post-Stroke Recovery
        • Epilepsy Treatment
    • Technology
    • Manufacturers
    • Patents
    • Figure 7 CORTICAL STIMULATION TECHNOLOGY PATENTS (% OF TOTAL CORTICAL STIMULATION PATENTS)
      • Deep Brain Stimulation
        • Description
        • Applications
        • Technology
        • Manufacturers
        • Patent Analysis
    • Figure 8 DEEP BRAIN STIMULATION TECHNOLOGY PATENTS (PERCENT OF TOTAL CORTICAL STIMULATION PATENTS)
      • SPINAL FUSION STIMULATORS
        • Description
        • Applications
        • Technology
        • Manufacturers
    • Table 8 SPINAL FUSION STIMULATOR MANUFACTURERS
      • Patent Analysis
    • IMPLANTABLE DRUG DIFFUSION PUMPS
      • Description
      • Applications
      • Technology
      • Microfluidics
      • Manufacturers
    • Table 9 IMPLANTABLE DRUG PUMP MANUFACTURERS
      • Patent Analysis
    • EAR IMPLANTS
      • Cochlear Implants
        • Description
        • Applications
        • Technology
          • Multi-Channel Cochlear Implants
          • Single-Electrode Cochlear Implants
          • Speech Coding
          • Miniaturization
          • Hybrid Cochlear Implants
          • Totally Implantable Cochlear Implants
          • Manufacturers
    • Table 10 COCHLEAR IMPLANT MANUFACTURERS
      • Patent Analysis
    • Figure 9 COCHLEAR IMPLANT PATENT HOLDERS (%)
      • Middle Ear Implants
        • Description
        • Applications
        • Technologies
          • Piezoelectric Middle Ear Implants
          • Electromagnetic Middle Ear Implants
          • Other Differences
    • Manufacturers
    • Table 11 MIDDLE EAR IMPLANT MANUFACTURERS
      • Patent Analysis
    • Figure 10 MIDDLE-EAR IMPLANT PATENT HOLDERS (%)
    • Figure 10 (CONTINUED)
      • OCULAR IMPLANTS
        • Description
        • Applications
        • Technologies
          • Cortical Implants
          • Retinal Implants
        • Epi-Retinal Implants
        • Boston Retinal Implant Project
        • Intraocular Retinal Prosthesis Group
        • Second Sight Medical Products, Inc.
        • Intelligent Medical Implants
        • Sub-Retinal Implants
        • Optobionics Corporation
        • Retina Implant GmbH
        • Hybrid Implants
    • Optic Nerve Stimulator
      • Patents
    • Figure 11 EYE IMPLANT PATENT HOLDERS (PERCENT OF TOTAL EYE IMPLANT PATENTS)
      • COMPONENTS AND SUPPLIES
        • Batteries
          • Lithium/Iodine Pacemaker Cells
          • Lithium/Silver Vanadium Oxide Defibrillator Cells
          • Lithium Carbon Monofluoride Cells
          • Lithium/Silver Vanadium Oxide/Fluorinated Carbon Cells
          • Lithium Ion Rechargeable Batteries
          • Other Technologies
        • Leads and Electrodes
    • REGULATORY/ LEGISLATIVE ISSUES
      • UNITED STATES
        • United States (Continued)
        • United States (Continued)
    • EUROPEAN UNION
      • European Union (Continued)
    • JAPAN
      • Japan (Continued)
    • GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS
      • SUMMARY
    • Figure 12 TRENDS IN GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS, 2006-2012 ($ BILLIONS)
      • DETAILED MARKET ESTIMATES AND PROJECTIONS, 2002-2009
    • Table 12 GLOBAL MARKET FORECAST FOR MICROELECTRONIC MEDICAL IMPLANTS BY TYPE OF IMPLANT, THROUGH 2012 ($ MILLIONS)
    • Figure 13 TRENDS IN MICROELECTRONIC MEDICAL IMPLANT APPLICATION MARKET SHARES, 2006 AND 2012 (PERCENT OF TOTAL IMPLANT SALES)
    • Figure 13 (CONTINUED)
      • CARDIAC IMPLANTS
    • Table 13 GLOBAL MARKET FORECAST FOR CARDIAC IMPLANTS, THROUGH 2012 ($ MILLIONS)
    • Figure 14 TRENDS IN CARDIOVASCULAR IMPLANT MARKET SHARES, 2006-2012 (PERCENT OF TOTAL CARDIO IMPLANT SALES MARKET)
    • Figure 14 (CONTINUED)
      • Pacemakers
        • Historical Sales of Pacemakers
        • Market Dynamics
    • Figure 15 RECENT GROWTH OF PACEMAKER SALES VS. OTHER INDICATORS, 2001-2006 (CAGR%)
      • Projected Sales of Pacemakers
    • Table 14 GLOBAL MARKET FORECAST FOR PACEMAKERS, THROUGH 2012 ($ MILLIONS)
      • Implanted Cardioverter Defibrillators
        • Historical Sales
        • Market Dynamics
          • New Indications
          • Low Market Penetration
    • Projected Sales
    • Table 15 GLOBAL MARKET FORECAST FOR ICD, THROUGH 2012 ($ MILLIONS)
      • Cardiac Resynchronization Therapy Devices
      • Implantable Loop Recorders
        • Historical Sales
        • Market Dynamics
          • Number of New Syncope Cases
    • Table 16 U.S. POPULATION AGED 55 AND OLDER, THROUGH 2012
      • Diagnostic Use of ILR
        • Projected Sales
    • Table 17 GLOBAL MARKET FORECAST FOR ILR, THROUGH 2012 ($ MILLIONS)
      • Cardiac Assist/ Replacement Devices
        • Historical Sales
        • Market Dynamics
    • Bridge to Transplant Applications
    • Destination Therapy Applications
    • Rate of Technology Adoption
    • Insurance Coverage
    • Constraints on Number of Qualified Surgeons
  • Projected Sales
    • Table 18 GLOBAL MARKET FORECAST FOR CARDIAC ASSISTS, THROUGH 2012 ($ MILLIONS)
      • NEUROSTIMULATORS
    • Table 19 GLOBAL MARKET FORECAST FOR NEUROSTIMULATORS, THROUGH 2012 ($ MILLIONS)
    • Figure 16 IMPLANTED NEUROSTIMULATOR MARKET SHARES, 2006 VS. 2012 (PERCENT OF IMPLANTED NEUROSTIMULATOR MARKET)
      • Spinal Nerve Stimulators
    • Table 20 GLOBAL MARKET FORECAST FOR SPINAL NERVE STIMULATORS, THROUGH 2012 ($ MILLIONS)
      • Spinal Nerve Stimulators for Chronic Pain
        • Historical Sales
        • Market Dynamics
    • Figure 17 SPINAL NERVE STIMULATOR CHRONIC PAIN MANAGEMENT MARKET PENETRATION, 2006 (%)
      • Projected Sales
    • Table 21 GLOBAL MARKET FORECAST FOR SPINAL NERVE STIMULATORS USED FOR CHRONIC PAIN MANAGEMENT, THROUGH 2012 ($ MILLIONS)
      • Spinal Nerve Stimulators for Spinal Cord Injury
        • Historical Sales
        • Market Dynamics
        • Projected Sales
    • Table 22 GLOBAL MARKET FORECAST FOR SPINAL NERVE STIMULATORS USED FOR SPINAL CORD INJURY, THROUGH 2012 ($ MILLIONS)
      • Spinal Nerve Stimulators for Urge Incontinence
        • Historical Sales
        • Market Dynamics
        • Projected Sales
    • Table 23 GLOBAL MARKET FORECAST FOR SPINAL STIMULATORS FOR MANAGING URGE INCONTINENCE, THROUGH 2012 ($ MILLIONS)
    • Vagal Nerve Stimulators
      • Historical Sales
      • Market Dynamics
    • Epilepsy Cases
    • Figure 18 VNS EPILEPSY MARKET PENETRATION, 2006 (%)
      • Depression
    • Future Sales
    • Table 24 GLOBAL MARKET FORECAST FOR VNS STIMULATORS, THROUGH 2012 ($ MILLIONS)
      • Deep Brain Stimulators
        • Historical Sales
        • Market Dynamics
    • Figure 19 DEEP BRAIN STIMULATION IMPLANT MARKET PENETRATION, 2006 (%)
      • Projected Sales
    • Table 25 GLOBAL MARKET FORECAST FOR DEEP BRAIN STIMULATORS, THROUGH 2012 ($ MILLIONS)
      • SPINAL FUSION STIMULATORS
        • Historical Sales
        • Market Dynamics
        • Projected Sales
    • Table 26 GLOBAL MARKET FORECAST FOR IMPLANTABLE SPINAL FUSION STIMULATORS, THROUGH 2012 ($ MILLIONS)
    • DRUG PUMPS
      • Historical Sales
      • Market Dynamics
    • Figure 20 GROWTH IN SALES OF IMPLANTABLE DRUG PUMPS VS. MAJOR TARGET MARKETS, 1998-2006 (CAGR%)
    • Figure 20 (CONTINUED)
      • Projected Sales
    • Table 27 GLOBAL MARKET FORECAST FOR IMPLANTABLE DRUG PUMPS, THROUGH 2012 ($ MILLIONS)
      • HEARING IMPLANTS
    • Table 28 GLOBAL MARKET FORECAST FOR HEARING IMPLANTS, THROUGH 2012 ($ MILLIONS)
      • Cochlear Implants
      • Historical Sales
      • Market Dynamics
    • Figure 21 COCHLEAR IMPLANT MARKET PENETRATION, 2006 (%)
    • Figure 21 (CONTINUED)
      • Projected Sales
    • Table 29 GLOBAL MARKET FORECAST FOR COCHLEAR IMPLANTS, THROUGH 2012 ($ MILLIONS)
      • Middle Ear Implants
        • Historical Sales
        • Market Dynamics
        • Projected Sales
    • Table 30 GLOBAL MARKET FORECAST FOR MIDDLE EAR IMPLANTS, THROUGH 2012 ($ MILLIONS)
      • EYE IMPLANTS
        • Historical Sales
        • Market Dynamics
        • Projected Sales
    • ACCESSORIES AND SUPPLIES
      • Historical Sales
      • Market Dynamics
      • Projected Sales
    • Table 31 GLOBAL MARKET FORECAST FOR IMPLANTABLE LEADS AND ELECTRODES, THROUGH 2012 ($ MILLIONS)
  • INDUSTRY STRUCTURE AND COMPETITION
    • MARKET SHARES
      • CARDIAC RHYTHM MANAGEMENT DEVICES
        • Pacemakers
    • Figure 22 CARDIAC PACEMAKER MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
      • Implantable Cardioverter Defibrillators
    • Figure 23 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
      • Implantable Loop Recorders
      • Heart Assist/ Replacement Devices
    • Figure 24 IMPLANTABLE HEART ASSIST/REPLACEMENT DEVICE MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
    • NEUROSTIMULATORS
      • Spinal Stimulators
    • Figure 25 SPINAL STIMULATOR MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
      • SPINAL FUSION STIMULATORS
    • Figure 26 SPINAL FUSION STIMULATOR MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
      • IMPLANTABLE DRUG INFUSION PUMPS
    • Figure 27 IMPLANTABLE DRUG PUMP MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
      • EAR IMPLANTS
      • Cochlear Implants
    • Figure 28 COCHLEAR IMPLANT MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
  • VENDOR PROFILES
    • ABIOMED, INC.
    • Table 32 ABIOMED FINANCIAL PERFORMANCE, THROUGH 2006 ($ MILLIONS)
      • ADVANCED BIONICS CORP.
      • ADVANCED NEUROMODULATION SYSTEMS, INC.
    • Table 33 ADVANCED NEUROMODULATION SYSTEMS FINANCIAL PERFORMANCE, THROUGH 2006* ($ MILLIONS)
      • ALLHEAR, INC.
    • ARROW INTERNATIONAL
      • BIOMET, INC.
      • BIOPHAN TECHNOLOGIES, INC.
      • BIOTRONIK GMBH
      • CLEVELAND FES CENTER
      • COCHLEAR, LTD.
      • CYBERONICS, INC.
    • Table 34 CYBERONICS, INC. FINANCIAL PERFORMANCE, THROUGH 2006 ($ MILLIONS)
      • THE DOBELLE INSTITUTE
      • ELA MEDICAL
      • ENVOY MEDICAL
      • FINETECH MEDICAL, LTD.
      • GUIDANT CORP.
    • Table 35 GUIDANT CORP. FINANCIAL PERFORMANCE, THROUGH 2005 ($ MILLIONS)
      • MED-EL
      • MEDTRONICS
    • Table 36 MEDTRONIC SALES IN SELECTED BUSINESS SEGMENTS, THROUGH 2006 ($ BILLIONS)
      • MICROMED TECHNOLOGY, INC.
      • MIV THERAPEUTICS, INC.
      • NEOPRAXIS, PTY. LTD.
      • NEUROCONTROL, INC.
      • NEUROPACE, INC.
      • OTOLOGICS, LLC
      • SOUNDTEC, INC.
      • ST. JUDE MEDICAL, INC.
    • Table 37 ST. JUDE MEDICAL FINANCIAL PERFORMANCE, THROUGH 2006 ($ MILLIONS)
      • SYMPHONIX DEVICES
      • THORATEC CORP.
      • THORATEC CORP. (CONTINUED)
      • WILSON GREATBATCH TECHNOLOGIES, INC.
    • Table 38 WILSON GREATBATCH IMD BATTERY SALES, THROUGH 2005 ($ MILLIONS)
      • WORLDHEART CORP.
        • WORLDHEART CORP. (CONTINUED)
    • Table 39 WORLDHEART CORP. FINANCIAL PERFORMANCE, THROUGH 2005 ($ MILLIONS)
  • LIST OF TABLES
    • Summary Table:
    • GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS BY APPLICATION, THROUGH 2012 ($ BILLIONS)
    • Table 1 HOSPITALIZATIONS, PHYSICIAN OFFICE VISITS, AND DEATHS DUE TO HEART DISEASE IN THE U.S., 2001-2002*
    • Table 2 HEART PACEMAKER MANUFACTURERS
    • Table 3 IMPLANTABLE DEFIBRILLATOR MANUFACTURERS
    • Table 4 CARDIAC RESYNCHRONIZATION DEVICE MANUFACTURERS
    • Table 5 HEART ASSIST DEVICES
    • Table 6 CARDIAC REPLACEMENT/ASSIST DEVICE MANUFACTURERS
    • Table 7 SPINAL CORD STIMULATOR MANUFACTURERS
    • Table 8 SPINAL FUSION STIMULATOR MANUFACTURERS
    • Table 9 IMPLANTABLE DRUG PUMP MANUFACTURERS
    • Table 10 COCHLEAR IMPLANT MANUFACTURERS
    • Table 11 MIDDLE EAR IMPLANT MANUFACTURERS
    • Table 12 GLOBAL MARKET FORECAST FOR MICROELECTRONIC MEDICAL IMPLANTS BY TYPE OF IMPLANT, THROUGH 2012 ($ MILLIONS)
    • Table 13 GLOBAL MARKET FORECAST FOR CARDIAC IMPLANTS, THROUGH 2012 ($ MILLIONS)
    • Table 14 GLOBAL MARKET FORECAST FOR PACEMAKERS, THROUGH 2012 ($ MILLIONS)
    • Table 15 GLOBAL MARKET FORECAST FOR ICD, THROUGH 2012 ($ MILLIONS)
    • Table 16 U.S. POPULATION AGED 55 AND OLDER, THROUGH 2012
    • Table 17 GLOBAL MARKET FORECAST FOR ILR, THROUGH 2012 ($ MILLIONS)
    • Table 18 GLOBAL MARKET FORECAST FOR CARDIAC ASSISTS, THROUGH 2012 ($ MILLIONS)
    • Table 19 GLOBAL MARKET FORECAST FOR NEUROSTIMULATORS, THROUGH 2012 ($ MILLIONS)
    • Table 20 GLOBAL MARKET FORECAST FOR SPINAL NERVE STIMULATORS, THROUGH 2012 ($ MILLIONS)
    • Table 21 GLOBAL MARKET FORECAST FOR SPINAL NERVE STIMULATORS USED FOR CHRONIC PAIN MANAGEMENT, THROUGH 2012 ($ MILLIONS)
    • Table 22 GLOBAL MARKET FORECAST FOR SPINAL NERVE STIMULATORS USED FOR SPINAL CORD INJURY, THROUGH 2012 ($ MILLIONS)
    • Table 23 GLOBAL MARKET FORECAST FOR SPINAL STIMULATORS FOR MANAGING URGE INCONTINENCE, THROUGH 2012 ($ MILLIONS)
    • Table 24 GLOBAL MARKET FORECAST FOR VNS STIMULATORS, THROUGH 2012 ($ MILLIONS)
    • Table 25 GLOBAL MARKET FORECAST FOR DEEP BRAIN STIMULATORS, THROUGH 2012 ($ MILLIONS)
    • Table 26 GLOBAL MARKET FORECAST FOR IMPLANTABLE SPINAL FUSION STIMULATORS, THROUGH 2012 ($ MILLIONS)
    • Table 27 GLOBAL MARKET FORECAST FOR IMPLANTABLE DRUG PUMPS, THROUGH 2012 ($ MILLIONS)
    • Table 28 GLOBAL MARKET FORECAST FOR HEARING IMPLANTS, THROUGH 2012 ($ MILLIONS)
    • Table 29 GLOBAL MARKET FORECAST FOR COCHLEAR IMPLANTS, THROUGH 2012 ($ MILLIONS)
    • Table 30 GLOBAL MARKET FORECAST FOR MIDDLE EAR IMPLANTS, THROUGH 2012 ($ MILLIONS)
    • Table 31 GLOBAL MARKET FORECAST FOR IMPLANTABLE LEADS AND ELECTRODES, THROUGH 2012 ($ MILLIONS)
    • Table 32 ABIOMED FINANCIAL PERFORMANCE, THROUGH 2006 ($ MILLIONS)
    • Table 33 ADVANCED NEUROMODULATION SYSTEMS FINANCIAL PERFORMANCE, THROUGH 2006* ($ MILLIONS)
    • Table 34 CYBERONICS, INC. FINANCIAL PERFORMANCE, THROUGH 2006 ($ MILLIONS)
    • Table 35 GUIDANT CORP. FINANCIAL PERFORMANCE, THROUGH 2005 ($ MILLIONS)
    • Table 36 MEDTRONIC SALES IN SELECTED BUSINESS SEGMENTS, THROUGH 2006 ($ BILLIONS)
    • Table 37 ST. JUDE MEDICAL FINANCIAL PERFORMANCE, THROUGH 2006 ($ MILLIONS)
    • Table 38 WILSON GREATBATCH IMD BATTERY SALES, THROUGH 2005 ($ MILLIONS)
    • Table 39 WORLDHEART CORP. FINANCIAL PERFORMANCE, THROUGH 2005 ($ MILLIONS)
  • LIST OF FIGURES
    • Summary Figure:
    • GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS BY APPLICATION, 2006-2012 ($ BILLIONS)
    • Figure 1 TRENDS IN U.S. CANCER DEATHS, 1998-2006
    • Figure 2 PACEMAKER PATENT HOLDERS (% OF TOTAL PACEMAKER PATENTS)
    • Figure 3 ICD PATENT HOLDERS (%)
    • Figure 4 CARDIAC RESYNCHRONIZATION DEVICE PATENT HOLDERS (% OF TOTAL PATENTS ISSUED THROUGH MARCH 1. 2007)
    • Figure 5 CARDIAC ASSISTANCE/REPLACEMENT DEVICE PATENT HOLDERS (PERCENT OF TOTAL U.S. PATENTS)
    • Figure 6 GASTRIC ELECTRICAL STIMULATION TECHNOLOGY PATENTS (% OF TOTAL CORTICAL STIMULATION PATENTS)
    • Figure 7 CORTICAL STIMULATION TECHNOLOGY PATENTS (% OF TOTAL CORTICAL STIMULATION PATENTS)
    • Figure 8 DEEP BRAIN STIMULATION TECHNOLOGY PATENTS (PERCENT OF TOTAL CORTICAL STIMULATION PATENTS)
    • Figure 9 COCHLEAR IMPLANT PATENT HOLDERS (%)
    • Figure 10 MIDDLE-EAR IMPLANT PATENT HOLDERS (%)
    • Figure 11 EYE IMPLANT PATENT HOLDERS (PERCENT OF TOTAL EYE IMPLANT PATENTS)
    • Figure 12 TRENDS IN GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS, 2006-2012 ($ BILLIONS)
    • Figure 13 TRENDS IN MICROELECTRONIC MEDICAL IMPLANT APPLICATION MARKET SHARES, 2006 AND 2012(PERCENT OF TOTAL IMPLANT SALES)
    • Figure 14 TRENDS IN CARDIOVASCULAR IMPLANT MARKET SHARES, 2006-2012 (PERCENT OF TOTAL CARDIO IMPLANT SALES MARKET)
    • Figure 15 RECENT GROWTH OF PACEMAKER SALES VS. OTHER INDICATORS, 2001-2006 (CAGR%)
    • Figure 16 IMPLANTED NEUROSTIMULATOR MARKET SHARES, 2006 VS. 2012 (PERCENT OF IMPLANTED NEUROSTIMULATOR MARKET)
    • Figure 17 SPINAL NERVE STIMULATOR CHRONIC PAIN MANAGEMENT MARKET PENETRATION, 2006 (%)
    • Figure 18 VNS EPILEPSY MARKET PENETRATION, 2006 (%)
    • Figure 19 DEEP BRAIN STIMULATION IMPLANT MARKET PENETRATION, 2006 (%)
    • Figure 20 GROWTH IN SALES OF IMPLANTABLE DRUG PUMPS VS. MAJOR TARGET MARKETS, 1998-2006 (CAGR%)
    • Figure 21 COCHLEAR IMPLANT MARKET PENETRATION, 2006 (%)
    • Figure 22 CARDIAC PACEMAKER MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
    • Figure 23 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
    • Figure 24 IMPLANTABLE HEART ASSIST/REPLACEMENT DEVICE MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
    • Figure 25 SPINAL STIMULATOR MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
    • Figure 26 SPINAL FUSION STIMULATOR MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
    • Figure 27 IMPLANTABLE DRUG PUMP MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
    • Figure 28 COCHLEAR IMPLANT MARKET SHARES, 2006 (PERCENT OF TOTAL SEGMENT SALES)
Back to Top